Yungjin Pharm Co Ltd (003520) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.078x

Based on the latest financial reports, Yungjin Pharm Co Ltd (003520) has a cash flow conversion efficiency ratio of 0.078x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩7.00 Billion ≈ $4.74 Million USD) by net assets (₩90.02 Billion ≈ $61.00 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Yungjin Pharm Co Ltd market capitalisation for the company's overall valuation and market capitalisation.

Yungjin Pharm Co Ltd - Cash Flow Conversion Efficiency Trend (2013–2024)

This chart illustrates how Yungjin Pharm Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Yungjin Pharm Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Yungjin Pharm Co Ltd ranked by their cash flow conversion efficiency. Explore Yungjin Pharm Co Ltd cash earnings quality to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Grigeo AB STU:WM8	0.060x
United Utilities Group PLC LSE:UU	0.310x
ENIGMATIG LIMITED NYSE MKT:EGG	0.008x
UVAT Technology Co Ltd TWO:3580	0.047x
CASH CONVERTERS INTL F:UKC	N/A
Turk Prysmian Kablo ve Sistemleri AS IS:PRKAB	0.312x
Avita Medical Ltd NASDAQ:RCEL	0.327x
Diploma PLC LSE:DPLM	0.105x

Annual Cash Flow Conversion Efficiency for Yungjin Pharm Co Ltd (2013–2024)

The table below shows the annual cash flow conversion efficiency of Yungjin Pharm Co Ltd from 2013 to 2024. View Yungjin Pharm Co Ltd (003520) share price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩89.80 Billion ≈ $60.86 Million	₩21.74 Billion ≈ $14.73 Million	0.242x	+312.24%
2023-12-31	₩89.63 Billion ≈ $60.74 Million	₩-10.22 Billion ≈ $-6.93 Million	-0.114x	+11.70%
2022-12-31	₩89.87 Billion ≈ $60.90 Million	₩-11.61 Billion ≈ $-7.87 Million	-0.129x	-261.92%
2021-12-31	₩104.89 Billion ≈ $71.08 Million	₩8.37 Billion ≈ $5.67 Million	0.080x	-37.03%
2020-12-31	₩114.43 Billion ≈ $77.55 Million	₩14.50 Billion ≈ $9.82 Million	0.127x	+57.98%
2019-12-31	₩115.75 Billion ≈ $78.44 Million	₩9.28 Billion ≈ $6.29 Million	0.080x	+602.43%
2018-12-31	₩111.61 Billion ≈ $75.63 Million	₩1.27 Billion ≈ $863.49K	0.011x	-56.66%
2017-12-31	₩119.65 Billion ≈ $81.08 Million	₩3.15 Billion ≈ $2.14 Million	0.026x	-10.13%
2016-12-31	₩106.17 Billion ≈ $71.95 Million	₩3.11 Billion ≈ $2.11 Million	0.029x	-66.56%
2015-12-31	₩100.42 Billion ≈ $68.06 Million	₩8.80 Billion ≈ $5.96 Million	0.088x	+42.11%
2014-12-31	₩100.79 Billion ≈ $68.30 Million	₩6.22 Billion ≈ $4.21 Million	0.062x	+6.13%
2013-12-31	₩102.45 Billion ≈ $69.43 Million	₩5.95 Billion ≈ $4.03 Million	0.058x	--

About Yungjin Pharm Co Ltd

KO:003520 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$126.67 Million

₩186.92 Billion KRW

Market Cap Rank

#18372 Global

#824 in Korea

Share Price

₩1022.00

Change (1 day)

+0.29%

52-Week Range

₩1019.00 - ₩2170.00

All Time High

₩17500.00